Market Watch  First-of-Its-Kind, Multidisciplinary Roundtable on Specialty Pharmacy Explores Access, Adherence and Cost for Fastest-Growing Segment of Prescription Drug Market

At Nearly 25 Percent of Overall Drug Spend, Specialty Pharmaceuticals Represent An Explosive Prescription Medications Market; Expected to Reach 40 Percent by 2030

A first-of-its-kind multidisciplinary roundtable discussion about specialty pharmacy and its impact on the health care system convened today in New York City. The discussion was moderated by Susan Dentzer, Editor-in-Chief of Health Affairs, one of the nation's leading health care journalists, and featured experts from clinical practice, disease and patient advocacy, bioethics, the pharmaceutical industry and pharmacy benefits management.

Roundtable panelists included Nancy Berlinger, Ph.D., Deputy Director and Research Scholar, The Hastings Center; Jacqueline Kosecoff, Ph.D., CEO, Prescription Solutions; J. Ross Maclean, M.D., MBA, Vice President, Health Services, Bristol-Myers Squibb; Lee N. Newcomer M.D., Senior Vice President of Oncology, Women's Health and Genetics, UnitedHealthcare; P.J. Weiner, Senior Manager, Advocacy Programs, National Multiple Sclerosis (MS) Society-NY; and Kenneth Bandler, MS patient advocate.
During the Roundtable discussion, participants discussed how to ensure that patients understand and use specialty pharmaceuticals correctly and achieve better health outcomes; which best practices can be leveraged for cost savings in the health care system; and how the future of these drugs will take shape.

To read entire article, click here